Fig. 7From: The impact of CBP expression in estrogen receptor-positive breast cancerCREBBP and KAT2A gene amplification in breast cancer cases with different ERĪ± and PR status. a Bars depict the association of CREBBP and KAT2A genes amplification (AMP) across different breast cancer subtypes (Luminal B: ERĪ±+/HER2+-high proliferation, Luminal A: ERĪ±+/HER2+-low proliferation, Triple negative: ERĪ±ā/HER2ā and HER2-overexpressed: HER2+). b, c The amplification status of CREBBP and KAT2A genes are depicted for b ERĪ±+ā(green) and ERĪ±ā (orange) samples and for c PR+ (green) and PRā (orange) samples. d The distribution of breast cancer patients who received hormonal therapy according to their CREBBP and KAT2A gene amplification status. pā<ā0.05 is statistically significantBack to article page